Top 51 alternative sites to evrysdi.com
-
evrysdi-hcp.com
-
togetherinsma.com
-
togetherinsma.pt
-
hcp.togetherinsma.ca
-
smauk.org.uk
-
signsofsma.com
-
smasupport.com
-
smamalaysia.org.my
-
spinalmuscularatrophy.net
-
hcp.togetherinsma.se
-
hcp.togetherinsma.com.tr
-
our-sma-angels.com
-
smaaustralia.org.au
-
sinaisdeame.pt
-
koselugo.com
-
yervoy.com
-
xyrem.com
-
tamiflu.com
-
ocrevus.com
-
sprycel.com
-
siklosusa.com
-
qbrexza.com
-
xofluza-hcp.com
-
pulmozyme.com
-
enspryng.com
-
esbriet.com
-
xofluza.com
-
erivedge.com
-
esbriethcp.com
-
gavreto-hcp.com
-
tecentriq.com
-
rituxanhycela.com
-
herceptin.com
-
hemlibra.com
-
tecentriq-hcp.com
-
enspryng-hcp.com
-
alecensa.com
-
rozlytrek.com
-
strokeawareness.com
-
cellcept.com
-
gavreto.com
-
rituxan-hcp.com
-
gazyva-hcp.com
-
gazyva.com
-
genentech-pro.com
-
rituxan.com
-
huntingtonsdisease.com
-
genentech-forum.com
-
screenyourlungs.org
-
genentechoncology.com
-
genentechhemophilia.com
Evrysdi®️ (risdiplam) | Approved Pediatric & Adult SMA treatment
Evrysdi®️ (risdiplam) is a treatment for spinal muscular atrophy (SMA) in patients 2 months of age and older. See full safety for more information.
Spinal Muscular Atrophy | Together in SMA
Learn about spinal muscular atrophy (SMA), a neuromuscular disease that causes loss of motor function and muscle atrophy, and care options for children and adults with SMA.
Spinal Muscular Atrophy | Together in SMA
Learn about spinal muscular atrophy (SMA), a neuromuscular disease that causes loss of motor function and muscle atrophy, and care options for children with SMA.
Spinal Muscular Atrophy | Together in SMA HCP
Learn about spinal muscular atrophy (SMA), a neuromuscular disease, and how a genetic test for SMA is performed to confirm diagnosis.
Spinal Muscular Atrophy UK - SMA Charity
Spinal Muscular Atrophy UK offer free confidential information, emotional support and practical advice guidance to anyone affected by Spinal Muscular Atrophy in the UK.
Spinal muscular atrophy (SMA) symptoms - SMA Type 1, SMA Type 2
Spinal muscular atrophy develops in babies less than 6 months old (SMA Type 1) and can appear in babies between 7-18 months old (SMA Type 2). Learn how to spot them
SMA Support Inc., Home of Spinal Muscular Atrophy
Dedicated to providing information, support and help for anyone facing the incurable genetic disease Spinal Muscular Atrophy (SMA). Learn about the disease, research, treatments, and life with the disease, speak with others in similar positions.
Spinal Muscular Atrophy Malaysia | SMAMalaysia
Penyakit Spinal Muscular Atrophy (SMA). SMA ialah penyakit genetik yang disebabkan oleh kerosakan pada sel saraf yang dipanggil "neuron motor" yang berada di saraf tunjang. Layari www.smamalaysia.org.my
Spinal Muscular Atrophy Health Info & Community
Learn about spinal muscular atrophy including symptoms, diagnosis, treatment, patient stories, & more from an SMA community perspective.
Author: Chaz Hayden
Spinal muskelatrofi | Together in SMA Hälso- och sjukvårdspersonal
Learn about spinal muscular atrophy (SMA), a neuromuscular disease, and how a genetic test for SMA is performed to confirm diagnosis.
Spinal Müsküler Atrofi | Together in SMA Sağlık Meslek Mensubu
Learn about spinal muscular atrophy (SMA), a neuromuscular disease, and how a genetic test for SMA is performed to confirm diagnosis.
Our SMA Angels...
Come meet children dealing with Spinal Muscular Atrophy (SMA), read their stories, see their faces. These little angels will touch your heart!
Author: Laura Stants
Spinal Muscular Atrophy: Causes, Symptoms, & Treatment
SMA Australia | Ensuring our community is heard | SMA Type 1 | SMA Type 2 | SMA Type 3
Sintomas atrofia muscular espinal (AME) - AME Tipo 1, AME Tipo 2
Spinal muscular atrophy develops in babies less than 6 months old (SMA Type 1) and can appear in babies between 7-18 months old (SMA Type 2). Learn how to spot them
NF1 PN Treatment | KOSELUGO® (selumetinib) 10 mg & 25 mg capsules
KOSELUGO® (selumetinib), an FDA approved prescription medicine to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas.
Could YERVOY® (ipilimumab) be right for you?
YERVOY is a prescription medicine used in adults and children 12 years of age and older to treat melanoma. See Indication, Important Safety Information, and Boxed Warning.
XYREM® - Treatment for Narcolepsy with Cataplexy and Excessive Daytime Sleepiness
XYREM® (sodium oxybate)—Now approved for use in adults and children ages 7 and older to help treat cataplexy and excessive daytime sleepiness (EDS) in narcolepsy. See XYREM® prescribing information & BOXED Warning about serious side effects, CNS depression, misuse and abuse.
Tamiflu® (oseltamivir phosphate) | Prescription Flu Treatment
Tamiflu® (oseltamivir phosphate) is an antiviral medicine for treatment of flu in people 2 weeks of age and older and for prevention of flu in people 1 year of age and older. See full safety for more information.
OCREVUS® (ocrelizumab) | Multiple Sclerosis (MS) Treatment
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Other sites like evrysdi com
Because everyday moments matter… I’ve Got SPRYCEL® (dasatinib).
SPRYCEL® (dasatinib) is used to treat adults and children 1 year of age and older with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Please see Indication and Important Safety Information.
Hydroxyurea-based treatment for pediatric patients with sickle cell anemia – Siklos® (hydroxyurea)
Siklos® is the first and only FDA-approved prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusion in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. See Important Safety Information and Boxed Warning about myelosuppression and malignancies.
Author: Super User
QBREXZA® (glycopyrronium) Cloth | Excessive Underarm Sweating Option
QBREXZA is the first and only prescription cloth towelette approved to treat excessive underarm sweating (primary axillary hyperhidrosis) in people 9 years of age and older. See Important Safety Information, Full Prescribing Information, including Patient Product Information, and Instructions for Use on QBREXZA.com.
Some websites with similar theme to evrysdi.com include:
Single-dose Flu Antiviral | XOFLUZA® (baloxavir marboxil) HCP
Find information for HCPs about XOFLUZA® (baloxavir marboxil), a single-dose **** antiviral treatment for influenza. See full safety for more information.
Cystic Fibrosis Treatment Option | Pulmozyme® (dornase alfa)
Pulmozyme® (dornase alfa) is a nebulized cystic fibrosis (CF) treatment option to help manage CF symptoms. See full safety for more information.
ENSPRYNG™ (satralizumab) | Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment
Learn about ENSPRYNG™ (satralizumab), a self-administered, monthly treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD). See full safety for more information.
Idiopathic Pulmonary Fibrosis (IPF) Treatment | Esbriet® (pirfenidone)
Learn about Esbriet® (pirfenidone), a medication for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
XOFLUZA® (baloxavir marboxil) | Prescription Flu Treatment
Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription flu treatment that attacks the flu virus at its source. See full safety for more information.
Erivedge® (vismodegib) | Advanced Basal Cell Carcinoma (aBCC) Treatment
Learn about Erivedge® (vismodegib) as a basal cell carcinoma treatment option for both metastatic and locally advanced carcinoma. See full safety, Boxed Warning, and Medication Guide for more information.
Esbriet® (pirfenidone) Information for Healthcare Professionals
Learn about Esbriet® (pirfenidone) as a possible treatment option for IPF, a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
GAVRETO® (pralsetinib) for RET+ mNSCLC & Advanced Thyroid Cancer | HCP
Learn about GAVRETO (pralsetinib) for RET+ metastatic NSCLC or advanced thyroid cancer. See important safety for more information.
Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, Advanced Melanoma & mUC | TECENTRIQ® (atezolizumab)
Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), Advanced Melanoma & Advanced Bladder Cancer (mUC) | TECENTRIQ® (atezolizumab)
RITUXAN HYCELA for FL, DLBCL and CLL
Learn about RITUXAN HYCELA® for subcutaneous injection, a prescription antibody therapy used for FL, DLBCL and CLL. See important safety including Boxed Warnings for more information.
HER2+ Cancer Treatment Option | Herceptin® (trastuzumab)
Find information about Herceptin®, a treatment for Early and Metastatic **** Cancer and Stomach/GEJ Cancer. See full safety & Boxed Warnings for more information.
HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment
Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety and BOXED WARNING.
TECENTRIQ® (atezolizumab) HCP | Efficacy, Safety, PI & MOA
Information for healthcare professionals about the safety, efficacy, dosing, prescribing information and mechanism of action for TECENTRIQ® (atezolizumab). See full safety for additional information.
ENSPRYNG™ (satralizumab) | Efficacy, Safety, & Prescribing Information
ENSPRYNG™ (satralizumab) is an interleukin-6 (IL-6) receptor antagonist indicated as monotherapy or with immunosuppressive therapy for the treatment of NMOSD. See full safety for more information.
ALECENSA® (alectinib) and Information for Patients
Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.
ROZLYTREK (entrectinib) ROS1 & TRK Inhibitor
Learn about ROZLYTREK (entrectinib), a treatment option for ROS1+ mNSCLC and certain NTRK fusion-positive solid tumors. See full safety for more information.
**** Information and Resources | **** Awareness
Learn about sudden signs of ****, **** risk factors, and why it is important to act immediately when reponding to a ****.
What else evrysdi.com alternative websites
CellCept® (mycophenolate mofetil) | Transplant Rejection Medication
Learn about the CellCept® Co-pay Card and how CellCept (mycophenolate mofetil) is used for people who have had a kidney, heart, or liver transplant. See full safety for more information.
RET+ mNSCLC & Advanced Thyroid Cancer Treatment | GAVRETO® (pralsetinib) Patient
Learn about GAVRETO for RET+ metastatic non-small cell lung cancer (mNSCLC) or advanced thyroid cancer. See important safety for more information.
Treatment for RA, NHL, CLL, GPA, MPA and PV | RITUXAN® (rituximab)
HCP info about RITUXAN® (rituximab) treatment for RA, NHL, CLL, GPA, MPA and PV including indications, dosing, efficacy and support. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more information.
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
Learn about GAZYVA® (obinutuzumab) for first-line, R/R follicular lymphoma & first-line CLL. See important safety including Boxed Warnings for more information.
Genentech Pro
Find information on Genentech's breakthrough medicines led by innovative science. Genentech is a proud member of the Roche Group.
RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA & PV
Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV. See full safety and Boxed Warning for more information.
Huntington's Together | Sharing Wisdom from the Community
Learn about HD and find inspiration in the experiences, advice, and tips shared by the Huntington's disease community.
Genentech Forum | Managed Care Resources
Find helpful resources for managed care and health system decision-makers from Genentech, including oncology cost containment trends and care management workshops.
ScreenYourLungs.org | Lung Cancer Screening
Surviving lung cancer starts with a scan. Find out how you can get a lung cancer screening today.
Cancer Information & Resources | Genentech Oncology
Find cancer information & resources. Explore new research in cancer & learn how Genentech is dedicated to investigating diverse biological pathways & disease targets.
Genentech in Hemophilia | We will continue to deliver on the needs of the hemophilia patient community
With your help, we will continue to deliver on the needs of the hemophilia patient community. That is our commitment to you.
